Skip to main content
Caplight Logo









Insightec

Insightec

Private
IsraelHealthcare & Life Scienceshttps://insightec.com/

Last Round

IPO

Oct 1, 2025

Est. Valuation

$375M

Total Funding Raised

$966.65M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Insightec is a medical technology company that develops and commercializes MRI-guided focused ultrasound devices for non-invasive treatments of various oncology and neurology conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

MR-guided focused ultrasoundMRgFUSfocused ultrasoundnon-invasive surgeryessential tremor treatmentParkinson's disease treatmentincisionless surgerynon-invasive brain surgeryultrasound ablationthermal ablationtherapeutic ultrasoundmedical deviceneurosurgery technologyExablate Neurouterine fibroid treatmentneuroscience drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insightec Comparables

Compare Insightec with similar companies based on industry and business-model similarity.

Insightec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chongqing Haifu Medical Technology Co., Ltd.
78%
HistoSonics
78%
Image Guided Therapy
78%

Insightec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOOct 1, 2025
Series GJun 18, 2024
DebtSep 1, 2022
Series FMar 6, 2020
Series EJan 31, 2018
Series E
Dec 14, 2017

Key People

Founding team and executive leadership

Kobi Vortman

President & CEO

Executive Team

Maurice R. Ferre

CEO and Chairman

Executive Team

Patrick Clingan

Chief Financial Officer

Executive Team

Ron Karie

CFO

Executive Team

Insightec Investors

Notable investors and investment history

Insightec investors
InvestorRounds
Perceptive AdvisorsSeries G, Debt
MedTech AdvisorsConvertible Debt, Series E, Series C, Series B, Series D Extension, Series D
GE CapitalSeries B
Ally Bridge GroupSeries G
York Capital ManagementSeries G, Series E, Series D, Series D Extension
Gilmartin CapitalSeries G
Nexus NeuroTech VenturesSeries G

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Job posting reveals a strategic alliance with CRL as part of its core portfolio.

  • May 11, 2026

    Partnered with LOTUS Neuro as part of core portfolio.

Insightec Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insightec Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersIsrael
Employee Range489
Year Founded1999
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?